244.76
+0.32(+0.13%)
Currency In USD
| Previous Close | 244.44 |
| Open | 244.29 |
| Day High | 245.99 |
| Day Low | 243.59 |
| 52-Week High | 293.81 |
| 52-Week Low | 199.92 |
| Volume | 239,554 |
| Average Volume | 1.08M |
| Market Cap | 35.87B |
| PE | 25.03 |
| EPS | 9.78 |
| Moving Average 50 Days | 252.59 |
| Moving Average 200 Days | 253.86 |
| Change | 0.32 |
If you invested $1000 in ResMed Inc. (RMD) 10 years ago, it would be worth $5,042.44 as of December 27, 2025 at a share price of $244.76. Whereas If you bought $1000 worth of ResMed Inc. (RMD) shares 5 years ago, it would be worth $1,197.51 as of December 27, 2025 at a share price of $244.76.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Dec 18, 2025 9:05 PM GMT
SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 44th Annual J.P. Morgan Healthcare Confer
Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy
GlobeNewswire Inc.
Dec 08, 2025 2:00 PM GMT
Technology uses real-world sleep data and machine learning to help people with sleep apnea start and stay on therapySAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, b
Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025
GlobeNewswire Inc.
Oct 09, 2025 8:05 PM GMT
SAN DIEGO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2026 on Thursday, October 30, 2025, after the New York Stock Exchan